CCAP — Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Investment Income (NII): Reported at $0.38 per share, down from $0.45 in the previous quarter. Adjusted NII, after a voluntary incentive fee waiver of $0.04, was $0.42 per share.
• Net Asset Value (NAV): Declined to $18.27 per share from $19.10, attributed to market conditions and credit-specific depreciation.
• Investment Portfolio: Valued at approximately $1.6 billion, with net leverage at 1.3x, slightly above the target range of 1.1x to 1.3x.
• Dividend: Regular dividend reset to $0.34 per share, with three special dividends of $0.03 per share scheduled for 2026.

2. Strategic Updates and Business Highlights

• Fee Structure Changes: Base management fee reduced from 1.25% to 1% and incentive fee from 17.5% to 15%, effective April 1, 2026, to enhance competitiveness.
• Portfolio Management: Focus on first lien investments and noncyclical industries, with a conservative approach to new investments and increased diversification.
• Market Position: The company is leveraging a more attractive investment environment characterized by widening spreads and reduced competition.

3. Forward Guidance and Outlook

• Earnings Outlook: The reset dividend reflects a conservative near-term earnings outlook. The company is not expecting significant net portfolio growth but is actively rotating the portfolio into attractive opportunities.
• Liquidity Position: Strong liquidity with approximately $206 million available and $27 million in cash, with plans to refinance upcoming unsecured maturities.

4. Bad News, Challenges, or Points of Concern

• Increased Nonaccruals: Nonaccruals rose to 5.7% of cost and 3.6% of fair value, reflecting five new nonaccruals primarily in healthcare investments.
• Market Volatility: The operating environment is characterized by geopolitical uncertainty, mixed consumer sentiment, and persistent inflation, impacting credit markets.
• Credit Quality Concerns: The company faces challenges with certain investments, particularly in healthcare, which have been under stress due to various operational challenges.

5. Notable Q&A Insights

• Healthcare Sector Challenges: Management acknowledged that while certain healthcare investments are under stress, the issues are not broad-based and are being closely monitored.
• Inflation Impact: Ongoing wage inflation remains a concern, with management indicating that they do not expect a reversal in these trends, which could further pressure portfolio companies.
• Sponsor Support: There are concerns regarding the capacity of private equity sponsors to support troubled businesses, which may affect CCAP's business model in the current credit environment.
• Sun Life Acquisition: The acquisition of Crescent by Sun Life is expected to strengthen alignment and potentially enhance funding opportunities, although specific impacts on cost of debt funding were not detailed.

This summary encapsulates the key takeaways from CCAP's Q1 2026 earnings call, highlighting financial performance, strategic initiatives, and challenges faced in the current market environment.